官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

HEALTH REPORT - New Heart Drug Shows Promise in African Americans

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
MP3节目录音 MP3节目录音  PDF节目文稿 PDF节目文稿 
文章正文
同步字幕

This is Bob Doughty with the VOA Special English Health Report.

Heart failure is a disease where the heart cannot pump enough blood to the body. Fluid collects in the lungs. People who develop heart failure are generally older. They feel tired and short of breath. Half the people die within five years.

Heart failure affects an estimated five million Americans. But African Americans are two and one-half times more likely to develop it. Now, an experimental treatment appears to increase their chance of survival.

Heart failure is usually treated with drugs called ACE inhibitors. But research has suggested that these drugs do not work as well in blacks as in whites. The difference may be linked to lower levels of nitric oxide in the blood of African Americans with heart failure. This chemical in the body helps blood flow.

So a company in Massachusetts, NitroMed, developed a treatment called BiDil. This combines two existing medicines to increase the amount of nitric oxide in the blood. Earlier studies failed to prove its effectiveness. But those studies involved mostly white patients. Scientists later re-examined the results and saw signs that it did help black patients.

As a result, NitroMed began a study of more than one thousand black people. They took traditional drugs for heart failure and either BiDil or an inactive substance. The study found that the patients who took BiDil had a forty-three percent better chance of survival after one year. They also needed fewer hospital visits.

Doctor Anne Taylor, a professor at the University of Minnesota, reported on the study at a meeting of the American Heart Association. The findings appeared in The New England Journal of Medicine.

NitroMed has been preparing to ask for federal approval of its treatment. Such approval was rejected after the earlier studies.

Some people, though, are uneasy with the idea of what is known as a "race-based therapy." That is, a drug developed for just one group with a disease common in the general population. Yet some doctors think the new pill might help the larger population as well.

The heart association says heart failure can be caused by disorders present at birth, or by a virus that damages the heart muscle. But it says the same things linked to heart attacks can also cause heart failure. These include smoking, being overweight, eating high-fat foods and not getting exercise.

This VOA Special English Health Report was written by Cynthia Kirk. This is Bob Doughty.

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台